To become the elite top percent of the wealthiest people in the world you need correct timing to be profitable. In the Real Estate Business we all heard the same phrase over and over again “ Location, Location, Location”, the same applies in the trading world; “Timing, Timing, Timing” Timing is everything.

Unfortunately the enormous catastrophe of the earthquake that hit Nepal India and Mount Everest, this what influence the market and what provide people in the trading world with a great wealth.

As you can see CNBC Covers the financial overview of this disaster:

The Next crucial timing is announcements made by companies like Apple:

Also very important timing is Financial Announcements as you can find them on our ECONOMIC CALENDAR:

In Conclusion Timing is everything in Trading World

If you find this article helpful share it.

Many of us lost trades , felt desperate and wanted to stop , so was I until I found out the secrets of getting back my losses. it's actually simple when I look at it and it is something that you can easily learn and do, I worked hard on this technique so please take it seriously, enjoy

Secret # 1

Lost a trade? it’s ok, it happens. Double the amount of The next trade.
Example: If you lost $25 your next trade should be $50.

If you also lost the next trade what happens then ?

It’s also ok, you need to double up once again the next trade.

Example: Now you lost $50 the next trade should be $100

The statistics say you can’t have a losing trade 6 times in a row - so on the sixs trade you will gain your investment back.

* this secret applies only while trading the same asset and by correcting your self while trading.

Secret # 2

It's not a secret that Signals Binary gaining monthly success over 70% each month for the last four years, Using Signals Binary Signals will provide you the advantage that was explained in Secret # 1

Here are the results for the past 4 years:

Celebrations of the collapse of Comcast's CMCSA +0.8% $45 billion takeover of Time Warner Cable TWC -0.59% may prove short-lived. Instead of a cable sector with lower debt loads and more cash available to bear the brunt of falling subscription prices or added capital investment, U.S. consumers are now likely to get their service from increasingly leveraged providers who may not have the financial wherewithal to handle the industry’s continued upheaval and its chronic spending needs.

Conventional wisdom since Comcast launched its merger effort for Time Warner Cable in early 2014 was that the nation’s largest cable provider was seeking to use consolidation as a means to throttle the broadband speeds of choice-constrained users, jack up prices, and strong arm content providers at the negotiating table. That narrative carried the day and it’s no surprise that Comcast is now toying with abandoning its merger completely, amid objections from the Federal Communications Commission and Department of Justice, according to a report from Bloomberg.

However, the consolidation of the cable sector is also as much a financial story as it is one about industry organization and competitive behavior.

Those in fear of a cable monopoly or oligopoly will claim victory when and if Comcast formally abandons its Time Warner Cable bid in the face of un-winnable regulatory hurdles. But, they’ll then have to hope service and pricing improves at a time when the finances of the cable industry are becoming far more stretched.

That’s not a sure bet, especially in an era of cord cutting and spiraling content costs, particularly in sports programming.

Ask us about our FREE financial advice program: 

Other top stories:

6 Top Reasons Traders Fail - Why You Need Signals

All Your Brokers and Signals in 1 Place - Binary Trade Center

How I Made Over $30,000 a Year by Investing in Binary Options

Follow us and SHARE this story on Facebook:  

Teva Pharmaceutical Industries made an unsolicited offer to buy Mylan for about $40.1 billion, in the drug industry's largest takeover attempt this year.

Teva, the world's biggest maker of generic medicines, offered $82 a share in cash and stock, according to a statement. That's about 23 percent above Mylan's closing price April 16, the day before Bloomberg News reported Teva was considering a bid. Mylan, which says it makes about one of every 11 drugs prescribed to Americans, has said it wants to stay independent and that a combination with Teva would face antitrust hurdles.

The deal would create a generics powerhouse with more than $27 billion in revenue and re-establish Teva as the unchallenged giant in the industry. The Israeli company has lost market share to Indian manufacturers such as Sun Pharmaceutical Industries Chief Executive Officer Erez Vigodman has pledged to look for deals as Teva's best-selling product, a branded treatment for multiple sclerosis called Copaxone, faces potential competition from generics.

"The attraction for Teva is that this deal would immediately allow them to grow and reduce their exposure to the impending drop in Copaxone sales," said Sam Fazeli, an analyst at Bloomberg Intelligence in London. "We still would have to consider the ramifications of antitrust regulation."

Buying Mylan would restart Teva's strategy of acquiring other generic-drug makers. The company had slowed acquisitions in that area in recent years, favoring deals for branded-drug companies such as the $3.5 billion purchase, announced last month, of Auspex Pharmaceuticals Inc. That deal, the largest since Vigodman became CEO in February 2014, will give Teva medications that curb tics and other movement disorders.

Ask us about our FREE financial advice program: 

Other top stories:

6 Top Reasons Traders Fail - Why You Need Signals

All Your Brokers and Signals in 1 Place - Binary Trade Center

How I Made Over $30,000 a Year by Investing in Binary Options

Follow us and SHARE this story on Facebook: